Synthesis and in vitro evaluation of pseudosaccharinamine derivatives as potential elastase inhibitors.

[1]  H. Otto,et al.  Pseudosaccharin amine derivatives: synthesis and elastase inhibitory activity. , 2005, Die Pharmazie.

[2]  M. Toda,et al.  Clarification of mechanism of human sputum elastase inhibition by a new inhibitor, ONO-5046, using electrospray ionization mass spectrometry. , 2002, Bioorganic & medicinal chemistry letters.

[3]  H. Ohbayashi.  Current synthetic inhibitors of human neutrophil elastase , 2002 .

[4]  E. Canet,et al.  Dual inhibition of human leukocyte elastase and lipid peroxidation: in vitro and in vivo activities of azabicyclo[2.2.2]octane and perhydroindole derivatives. , 1997, Journal of medicinal chemistry.

[5]  Y. Nakayama,et al.  Non-peptidic inhibitors of human neutrophil elastase: the design and synthesis of sulfonanilide-containing inhibitors. , 1996, Bioorganic & medicinal chemistry.

[6]  O. Prakash,et al.  Design, synthesis, and in vitro inhibitory activity toward human leukocyte elastase, cathepsin G, and proteinase 3 of saccharin-derived sulfones and congeners. , 1996, Bioorganic & medicinal chemistry.

[7]  R. Gordon,et al.  Phosphonates and phosphinates: novel leaving groups for benzisothiazolone inhibitors of human leukocyte elastase. , 1995, Journal of medicinal chemistry.

[8]  R. Gordon,et al.  Orally bioavailable benzisothiazolone inhibitors of human leukocyte elastase. , 1995, Journal of medicinal chemistry.

[9]  E. Huber,et al.  Inhibition of human neutrophil elastase with peptidyl electrophilic ketones. 2. Orally active PG-Val-Pro-Val pentafluoroethyl ketones. , 1994, Journal of medicinal chemistry.

[10]  J. Williams,et al.  Nonpeptidic inhibitors of human leukocyte elastase. 2. Design, synthesis, and in vitro activity of a series of 3-amino-6-arylopyridin-2-one trifluoromethyl ketones. , 1994, Journal of medicinal chemistry.

[11]  P. Bernstein,et al.  Nonpeptidic inhibitors of human leukocyte elastase. 3. Design, synthesis, X-ray crystallographic analysis, and structure-activity relationships for a series of orally active 3-amino-6-phenylpyridin-2-one trifluoromethyl ketones. , 1994, Journal of medicinal chemistry.

[12]  P. Warner,et al.  Non-peptidic inhibitors of human leukocyte elastase. 1. The design and synthesis of pyridone-containing inhibitors. , 1994, Journal of medicinal chemistry.

[13]  P. Bernstein,et al.  Synthetic Inhibitors of Elastase , 1994, Medicinal research reviews.

[14]  M. Suzuki,et al.  ONO-5046, a novel inhibitor of human neutrophil elastase. , 1991, Biochemical and biophysical research communications.

[15]  E. Meyer,et al.  Crystallographic analysis of the inhibition of porcine pancreatic elastase by a peptidyl boronic acid: structure of a reaction intermediate. , 1989, Biochemistry.

[16]  W. Bode,et al.  Primary structure of human neutrophil elastase. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Huber,et al.  X‐ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. , 1986, The EMBO journal.

[18]  Stein Rl,et al.  Mechanism of inactivation of human leukocyte elastase by a chloromethyl ketone: kinetic and solvent isotope effect studies. , 1986 .

[19]  M. Dixon.  The determination of enzyme inhibitor constants. , 1953, The Biochemical journal.

[20]  T. Kinoshita,et al.  True interaction mode of porcine pancreatic elastase with FR136706, a potent peptidyl inhibitor. , 2003, Bioorganic & medicinal chemistry letters.

[21]  P. Bernstein,et al.  Nonpeptidic inhibitors of human leukocyte elastase. 5. Design, synthesis, and X-ray crystallography of a series of orally active 5-aminopyrimidin-6-one-containing trifluoromethyl ketones. , 1995, Journal of medicinal chemistry.

[22]  M. Bolognesi,et al.  Crystal structure and NMR investigation of the serine proteinase inhibitor MR889, a cyclic thiolic compound , 1993 .

[23]  N. Peet,et al.  Synthesis of peptidyl fluoromethyl ketones and peptidyl alpha-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G. , 1990, Journal of medicinal chemistry.